Abstract
Peripheral neuropathy is the most frequent neurological complication associated with human immunodeficiency virus type 1 (HIV) infection and advanced acquired immunodeficiency syndrome (AIDS). There are at least 6 patterns of HIV-associated peripheral neuroathy, although these diagnoses are often overlooked or misdiagnosed.
Distal symmetrical polyneuropathy (DSP) is the most common form of peripheral neuropathy in HIV infection. DSP occurs mainly in patients with advanced immunosuppression and may also be secondary to the neurotoxicity of several antiretroviral agents. Treatment of painful DSP is primarily symptomatic, while pathogenesis-based therapies are under investigation. Reduction or discontinuation of neurotoxic agents should be considered if possible.
Inflammatory demyelinating polyneuropathy (IDP) can present in an acute or chronic form. The acute form may occur at the time of primary HIV infection or seroconversion. Cerebrospinal fluid lymphocytic pleocytosis (10 to 50 cells/mm3) is helpful in the diagnosis of HIV-associated IDP. Treatment consists of immunomodulatory therapy.
Progressive polyradiculopathy (PP) most commonly occurs in advanced immunosuppression and usually is caused by cytomegalovirus (CMV) infection. Rapidly progressive flaccid paraparesis, radiating pain and paresthesias, areflexia and sphincter dysfunction are the cardinal clinical features. Rapid diagnosis and treatment with anti-CMV therapy are necessary to prevent irreversible neurological deficits resulting from nerve root necrosis.
Mononeuropathy multiplex (MM) that occurs in early HIV infection is characterised by self-limited sensory and motor deficits in the distribution of individual peripheral nerves. In advanced HIV infection, multiple nerves in two or more extremities or cranial nerves are affected. Treatment includes immunomodulation or anti-CMV therapy.
Autonomic neuropathy may be caused by central or peripheral nervous system abnormalities. Treatment is supportive with correction of metabolic or toxic causes. Diffuse infiltrative lymphocytosis syndrome (DILS) presents as a Sjögren’slike disorder with CD8 T cell infiltration of multiple organs. Antiretroviral therapy and steroids may be effective treatments.
Similar content being viewed by others
References
Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. In: Dyck PJ, editor. Peripheral neuropathies: new concepts and treatments. Philadelphia (PA): WB Saunders, 1992: 685–711
Simpson DM, Katzenstein DA, Hughes MD, the AIDS Clinical Trial Group 175/801 Study Team, et al. Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS 1998; 12: 2425–32
Tagliati M, Grinnel J, Goldbold J, et al. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol 1999; 56: 84–9
Hall CD, Snyder CR, Mesenheimer JA, et al. Peripheral neuropathy in a cohort of human immunodeficiency virus infected patients: incidence and relationship to other nervous system dysfunction. Arch Neurol 1991; 48: 1273–4
Snider WD, Simpson DM, Nielsen S, et al. Neurological complications of acquired immunodeficiency syndrome: analysis of 50 patients. Ann Neurol 1983; 14: 403–18
Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1 related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology 1994; 44: 1892–900
So YT, Holtzman DM, Abrams DJ, et al. Peripheral neuropathy associated with acquired immunodeficiency syndrome: prevalence and clinical features from a population-based survey. Arch Neurol 1988; 45: 945–8
Barohn RJ, Gronseth GS, LeForce BR, et al. Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals. Arch Neurol 1993;50: 167–71
Raphael SA, Price ML, Lischner HW, et al. Inflammatory demyelinating polyneuropathy in a child with symptomatic human immunodeficiency virus infection. J Pediatr 1991; 118: 242–5
Lacroix C, Vazeux R, Brousse N, et al. A neuropathological study of 10 HIV-infected children. Rev Neurol 1993; 149: 37–45
Janssen RS, Saykin AJ, Kaplan JE, et al. Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome. Ann Neurol 1988; 23: 49–53
Villa A, Foresti V, Confalonieri F. Autonomic nervous system dysfunction associated with HIV infection in intravenous heroin users. AIDS 1992; 6: 85–9
Cohen JR, Laundenslager M. Autonomic nervous system involvement in patients with human immunodeficiency virus infection. Neurology 1989; 39: 1111–12
Gherardi RK, Chretien F, Defau-Larue H, et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology 1998; 50: 1041–4
Mah V, Vartavarian LM, Akers MA, et al. Abnormalities of peripheral nerve in patients with human immunodeficiency virus infection. Ann Neurol 1988; 24: 713–17
De la Monte SM, Gabuzda DH, Ho DD, et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol 1988; 23: 485–92
Lipkin WI, Parry G, Kiprov D, et al. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 1985; 35: 1479–83
Rance NE, McArthur JC, Cornblath D, et al. Gracile tract degeneration in patients with sensory neuropathy and AIDS. Neurology 1988; 38: 265–71
Said G, Saimot AG, Tardieu M et al. Peripheral nerve disease in HIV-infected patients. In: Warlow CP, van Ginj J, editors. Major problems in neurology: 34. Neurological complications of HIV and AIDS. London: WB Saunders Company Ltd, 1998: 155–80
Cornblath DR, McArthur JC, Kennedy PGE, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987; 21: 32–40
Gherardi R, Labargy F, Mhiri C, et al. Necrotizing vasculitis and HIV replication in peripheral nerves [letter]. N Engl J Med 1989; 321: 685–6
Eidelberg D, Sostrel A, Vogel H, et al. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 1986; 36: 912–16
Said G, Lacroix C, Chemuilli P, et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1991; 29: 139–46
Batman PA, Miller ARO, Sedwick PM, et al. Autonomie denervation in jejunal mucosa of homosexual men infected with HIV. AIDS 1991; 5: 1247–52
Purba JS, Hoffman MA, Portegies P, et al. Decreased number of oxytoxin neurons in the paraventricular nucleus of the human hypothalamus in AIDS. Brain 1993; 116: 795–805
Wulff, EA, Simpson DM. HIV-associated neuropathy: recent advances in management. HIV Adv Res Ther 1998; 8(3): 23–9
Comblath DR, McArthur JC. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988; 38: 794–6
Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J AIDS 1995; 9: 153–61
Berger AR, Arezzo JC, Schaumburg HH, et al. 2′,3′-Dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 1993; 43: 358–62
Fumalaro G, Moretti S, Marcellini S, et al. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS 1997; 11: 185–90
Gill P, Rarick M, Bernstein-Singer M, et al. Treatment of advanced Kaposi’s sarcoma using combination of bleomycin and vincristine. Am J Clin Oncol 1990; 13: 315–19
Figg WD. Peripheral neuropathy in HIV patients after isoniazid therapy. Drug Intell Clin Pharm 1991; 25: 100–1
Ochonoski S, Verroust J, Bastuji-Garin S, et al. Thalidomide neuropathy: incidence and clinicoelectrophysiological findings in 42 patients. Arch Dermatol 1994; 130: 66–9
Vendrell J, Heredia C, Pujol M, et al. Guillain-Barre syndrome associated with seroconversion for anti-HTLV III. Neurology 1987; 37: 544
Misha BE, Sommers W, Koski CL, et al. Acute inflammatory demyelinating polyneuropathy in the acquired immunodeficiency syndrome. Ann Neurol 1985; 18: 131–2
Morgello S, Simpson DM. Multifocal cytomegalovirus demyelinating polyneuropathy associated with AIDS. Muscle Nerve 1994; 17: 176–82
Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993; 17: 32–7
Clifford DB, Buller RS, Mohammed S, et al. Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection. Neurology 1993; 43: 75–9
Miller RG, Parry CJ, Pfaeffl W, et al. The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 1988; 11: 857–63
Roullet E, Assuerus V, Gozlan J, et al. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive patients. Neurology 1994; 44: 2174–82
Freeman R, Roberts M, Friedman L, et al. Autonomic function and human immunodeficiency virus infection. Neurology 1990; 40: 575–80
Moulignier A, Authier FJ, Baudrimont M, et al. Peripheral neuropathy in HIV-infected patients with diffuse infiltrative lymphocytosis syndrome (DILS). Ann Neurol 1997; 41: 438–45
World Health Organization. Cancer pain relief, with a guide of opioid availability. 2nd ed. Geneva: World Health Organization, 1996
Kieburtz K, Simpson DM, Yiannoustsos C. A randomized trial of amitriptyline and mexiletene for painful neuropathy in HIV infection: the ACTG 242 Study Team. Neurology 1998; 51: 1682–8
Simpson DM, Olney R, McArthur J, et al. A placebo-controlled study of lamotrigine in the treatment of painful sensory polyneuropathy associated with HIV infection. Neurology. In press
Dorfman D, Dalton A, Khan A, et al. Treatment of painful distal sensory polyneuropathy in HIV-infected patients with a topical agent: results of an open-label trial of 5% lidocaine gel. AIDS 1999; 13: 1589–90
Shlay JC, Chaloner D, Max M, et al. Acupunture and amitrptyline for pain due to HIV-related peripheral neuropathy. JAMA 1998; 280: 1590–5
Dyck PJ, Peroutka S, Rask C, et al. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 1997; 48: 501–5
McArthur J, Yiannoutsos C, Simpson DM et al. A phase II trial of recombinant human nerve growth factor for sensory neuropathy associated with HIV. Neurology 2000; 54: 1080–8
Apfel SC, Kessler JA, Adornato BT, et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy: NGF Study Group. Neurology 1998; 51: 695–702
Jacobson MA. Treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. N Engl J Med 1997; 337(2): 105–14
So YT, Olney RK. The natural history of mononeuritis multiplex and simplex in HIV-infection. Neurology 1991; 41 Suppl. 1: 375
Freeman R. Autonomie failure and AIDS. In: Low PA, editor. Clinical autonomie disorders. Philadelphia (PA): Lippincott-Raven Publishers, 1997: 727–35
Fealey RD, Robertson D. Management of orthostatic hypotension. In: Low PA, editor. Clinical autonomie disorders. Philadelphia (PA): Lippincott-Raven Publishers, 1997: 763–75
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wulff, E.A., Wang, A.K. & Simpson, D.M. HIV-Associated Peripheral Neuropathy. Drugs 59, 1251–1260 (2000). https://doi.org/10.2165/00003495-200059060-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-200059060-00005